Page 10 - The Science of Infectious Diseases
P. 10
INDEX
Note: Boldface page numbers bacteria, 9–11, 10
indicate illustrations. diversity of, 11–12
Bartonella henselae, 27
acute lower respiratory Black Death (1346–1353),
infection, 7 27–29, 32
acute respiratory distress brain-eating amoeba
syndrome (ARDS), 40 (Naegleria fowleri), 18–19
Adalja, Amesh, 16 bubonic plague, 27–29
Aedes albopictus mosquito,
4–5, 48 Cabezuela, Jedidiah King, 24
AIDS (acquired Candida auris, 17
immunodefi ciency drug-resistant, 35, 53
syndrome), 31, 34–35 CD4 cells (T cells), 40
annual deaths from, 7 in HIV infection, 33–34
air travel, 7, 47–48 Centers for Disease Control
American Society of and Prevention (CDC), 20,
Nephrology, 41 26, 27, 37, 57
Anopheles mosquito, 5, 6, on COVID-19 variants, 43
29 on deaths from cryptococcal
Anthony, Simon J., 13 meningitis, 18
anthrax, 50–51 on drug-resistant Candida
Antibiotic Resistance Threats auris, 17, 53
in the United States (Centers on drug-resistant pathogens,
for Disease Control and 35
Prevention), 35 on E. coli infections/deaths,
antimicrobial resistance, 51–53 23
in Candida auris, 17, 53 on increase in vector-borne
defi nition of, 52 diseases, 44
most dangerous microbes on MRSA infections, 52
showing, 35 chikungunya virus, 44, 48
in plague bacterium, 29 chlamydia, 21
WHO action plan against, 53 cholera, 24
antiretroviral therapy, 32 Claverie, Jean-Michel, 51
artemisinin-based combination climate change, 48–51
therapies (ACTs), 52–53 Clostridioides diffi cile
avian fl u, 45, 46 (C. diffi cile), 35
59
